Local surgical, ablative, and radiation treatment of metastases

CA Cancer Journal for Clinicians

Volumn 59, Issue 3, 2009, Pages 145-170

  Timmerman, Robert D ^a   Bizekis, Costas S ^b   Pass, Harvey I ^b   Fong, Yuman ^c   Dupuy, Damian E ^d   Dawson, Laura A ^e   Lu, David ^f  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE DUCT FISTULA; BILE LEAKAGE; BLEEDING; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; CYTOREDUCTIVE SURGERY; GERM CELL TUMOR; HEART INFARCTION; HUMAN; KIDNEY CARCINOMA; LIVER DISEASE; LIVER FAILURE; LIVER METASTASIS; LIVER RESECTION; LUNG EMBOLISM; LUNG METASTASIS; MELANOMA; MICROMETASTASIS; OSTEOSARCOMA; PLEURA EFFUSION; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIATION INJURY; RADIOFREQUENCY ABLATION; REVIEW; SOFT TISSUE SARCOMA; STEREOTACTIC BODY RADIATION THERAPY; SURGICAL MORTALITY; SURGICAL TECHNIQUE; THORACOTOMY; VIDEOENDOSCOPY;

CATHETER ABLATION; COLORECTAL NEOPLASMS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; PNEUMONECTOMY; RADIOSURGERY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 65649120797     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.20013     Document Type: Review

References (183)

1. Kavanagh BD, Bradley J, Timmerman RD. Stereotactic irradiation of tumors outside the central nervous system. In: Halperin E, Perez C, Brady L, Wazer D, Freeman C, Prosnitz L, eds. Perez and Brady's Principles and Practice of Radiation Oncology. 5th ed. Baltimore: Lippincott, Williams, and Wilkins; 2007:389-390.
2. Glick JH, Kim K, Earl J. An ECOG randomized phase III trial of CHOP vs CHOP plus radiotherapy for intermediate grade early stage non-Hodgkin's lymphoma [abstract]. Proc Am Soc Clin Oncol. 1995;14:391. Abstract.
3. Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate-and high-grade non-Hodgkin's lymphoma. N Engl J Med. 1998;339:21-26. (Pubitemid 28304493)
4. O'ConnellMJ,HarringtonDP,EarleJD,etal. Chemotherapyfollowedbyconsolidationradiationtherapyforthetreatmentof clinicalstageIIaggressivehistologictypenon-Hodgkin'slymphoma.Cancer.1988;61: 1754-1758.(Pubitemid18112751)
5. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13:8-10.
6. NortonL,SimonR.TheNorton-Simonhypothesisrevisited.CancerTreatRe1986;70: 163-169.(Pubitemid16140378)
7. Simon R, Norton L. The Norton-Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens. Nat Clin Pract Oncol. 2006;3:406-407. (Pubitemid 44203808)
8. Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature. 2006;441:1068-1074. (Pubitemid 43990718)
9. SellS,DunsfordHA. Evidenceforthestemcelloriginofhepatocellularcarcinomaandcholangiocarcinoma. AmJPathol.1989;134:1347-1363.(Pubitemid19206321)
10. Pawlik T, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008;13:51-64.
11. StrasbergSM.Terminologyofliveranatomyandliverresections: coming-gripswithhepaticBabel.JAmCollSurg.1997;184:413-434.(Pubitemid27172831)
12. CoppaGF,EngK,RansonJH,GougeTH,LocalioSA. Hepaticresectionformetastaticcolonandrectalcancer. Anevaluationofpreoperativeandpostoperativefactors.AnnSurg.1985;202:203-208. (Pubitemid15041720)
13. NordlingerB,QuilichiniMA,ParcR,HannounL,DelvaE,HuguetC. Hepaticresectionforcolorectallivermetastases. Influenceonsurvivalofpreoperativefactorsandsurgeryforrecurrencesin80patients. AnnSurg.1987;205:256-263.(Pubitemid17037048)
14. SchlagP,HohenbergerP,HerfarthC. Resectionoflivermetastasesincolorectalcancer- competitiveanalysisoftreatmentresultsinsynchronousversusmetachronousmetastases. EurJSurgOncol.1990;16:360-365.(Pubitemid20250419)
15. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery. 1991;110:13-29.
16. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235:759-766. (Pubitemid 34547293)
17. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309-318; discussion 318-321. (Pubitemid 30191861)
18. HughesKS,SimonR,SonghorabodiS,etal. Resectionoftheliverforcolorectalcarcinomametastases:amulti- institutionalstudyofpatternsofrecurrence.Surgery.1986;100:278-284. (Pubitemid16070861)
19. JamisonRL,DonohueJH,NagorneyDM,RosenCB,HarmsenWS,IlstrupDM. Hepaticresectionformetastaticcolorectalcancerresultsincureforsomepatients. ArchSurg.1997;132:505-510;discussion511.(Pubitemid27215091)
20. KatoT,YasuiK,HiraiT,etal. Therapeuticresultsforhepaticmetastasisofcolorectalcancerwithspecialreference- effectivenessofhepatectomy: analysisofprognosticfactorsfor763casesrecordedat18institutions.DisColonRectum. 2003;46:S22-S31.(Pubitemid37266357)
21. Minagawa M, Makuuchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg. 2000;231:487-499. (Pubitemid 30185854)
22. Rosen CB, Nagorney DM, Taswell HF, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg. 1992;216:493-504; discussion 504-1495
23. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg. 1995;19:59-71.
24. [no authors listed]. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg. 1997;113:37-49.
25. Sternberg DI, Sonett JR. Surgical therapy of lung metastases. Semin Oncol. 2007;34:186-196. (Pubitemid 46874550)
26. Veronesi G, Petrella F, Leo F, et al. Prognostic role of lymph node involvement in lung metastasectomy. J Thorac Cardiovasc Surg. 2007;133:967-972. (Pubitemid 46435911)
27. PeuchotM,LibshitzHI.Pulmonarymetastaticdisease:radiologic- surgicalcorrelation.Radiology.1987;164:719-722.(Pubitemid17144929)
28. Seemann MD, Seemann O, Luboldt W, et al. Differentiation of malignant from benign solitary pulmonary lesions using chest radiography, spiral CT and HRCT. Lung Cancer. 2000;29:105-124. (Pubitemid 30645820)
29. CollieDA,WrightAR,WilliamsJR,Hashemi-MalayeriB,StevensonAJ,TurnbullCM. Comparisonofspiral- acquisitioncomputedtomographyandconventionalcomputedtomographyinthe assessmentofpulmonarymetastaticdisease.BrJRadiol.1994;67:436-444. (Pubitemid24148079)
30. Reinhardt MJ, Wiethoelter N, Matthies A, et al. PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images. Eur J Nucl Med Mol Imaging. 2006;33:134-139. (Pubitemid 43152879)
31. McCormack PM, Bains MS, Begg CB, et al. Role of video-assisted thoracic surgery in the treatment of pulmonary metastases: results of a prospective trial. Ann Thorac Surg. 1996;62:213-216; discussion 216-217.
32. RuschVW.Surgicaltechniquesforpulmonarymetastasectomy. SeminThoracCardiovascSurg.2002;14:4-9.(Pubitemid34467561)
33. Mutsaerts EL, Zoetmulder FA, Meijer S, Baas P, Hart AA, Rutgers EJ. Outcome of thoracoscopic pulmonary metastasectomy evaluated by confirmatory thoracotomy. Ann Thorac Surg. 2001;72:230-233. (Pubitemid 32643043)
34. Mutsaerts EL, Zoetmulder FA, Meijer S, Baas P, Hart AA, Rutgers EJ. Long term survival of thoracoscopic metastasectomy vs metastasectomy by thoracotomy in patients with a solitary pulmonary lesion. Eur J Surg Oncol. 2002;28:864-868. (Pubitemid 35402298)
35. Nakajima J, Takamoto S, Tanaka M, Takeuchi E, Murakawa T, Fukami T. Thoracoscopic surgery and conventional open thoracotomy in metastatic lung cancer. Surg Endosc. 2001;15:849-853.
36. Parsons AM, Detterbeck FC, Parker LA. Accuracy of helical CT in the detection of pulmonary metastases: is intraoperative palpation still necessary? Ann Thorac Surg. 2004;78:1910-1916; discussion 1916-1918. (Pubitemid 39556260)
37. Ercan S, Nichols FC 3rd, Trastek VF, et al. Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma. Ann Thorac Surg. 2004;77:1786-1791. (Pubitemid 38530026)
38. Okumura S, Kondo H, Tsuboi M, et al. Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients. J Thorac Cardiovasc Surg. 1996;112:867-874. (Pubitemid 26339257)
39. Pfannschmidt J, Klode J, Muley T, Dienemann H, Hoffmann H. Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients. Ann Thorac Surg. 2006;81:448-454. (Pubitemid 43120533)
40. Veronesi G, Petrella F, Leo F, et al. Prognostic role of lymph node involvement in lung metastasectomy. J Thorac Cardiovasc Surg. 2007;133:967-972. (Pubitemid 46435911)
41. Snyder CL, Saltzman DA, Ferrell KL, Thompson RC, Leonard AS. A new approach to the resection of pulmonary osteosarcoma metastases. Results of aggressive metastasectomy. Clin Orthop Relat Res. 1991:247-253.
42. Downey RJ. Surgery for colorectal and sarcomatous pulmonary metastases: history, current management, and future directions. Thorac Surg Clin. 2006;16:133-137, v-vi.
43. Horan TA, Santiago FF, Araujo LM. The benefit of pulmonary metastectomy for bone and soft tissue sarcomas. Int Surg. 2000;85:185-189.
44. Ketchedjian A, Daly B, Luketich J, Fernando HC. Minimally invasive techniques for managing pulmonary metastases: video-assisted thoracic surgery and radiofrequency ablation. Thorac Surg Clin. 2006;16:157-165. (Pubitemid 44240256)
45. Gillams AR. The use of radiofrequency in cancer. Br J Cancer. 2005;92:1825-1829. (Pubitemid 40826126)
46. Lencioni RA. Tumor Radiofrequency Ablation Italian Network (TRAIN): long-term results in hepatic colorectal cancer metastases. Presented at Radiological Society of North America, 90th Scientific Assembly and Annual Meeting, Chicago, Ilinois, November 28-December 3, 2004.
47. MachiJ,OishiAJ,SumidaK,etal.Long- termoutcomeofradiofrequencyablationforunresectablelivermetastasesfrom colorectalcancer:evaluationofprognosticfactorsandeffectivenessinfirst-andsecond- linemanagement.CancerJ.2006;12:318-326.(Pubitemid44285559)
48. Kim YJ, Raman SR, Yu NC, Busuttil RW, Tong M, Lu DSK. Radiofrequency ablation of hepatocellular carcinoma: can subcapsular tumors be safely ablated? AJR Amer J Roentgenol. 2008;190:1029-1034.
49. EliasD,DiPietroantonioD,GachotB,MenegonP,HakimeA,DeBaereT. Liverabscessafterradiofrequencyablationoftumorsinpatientswithabiliary tractprocedure.GastroenterolClinBiol.2006;30:823-827.(Pubitemid44196101)
50. LuDS,RamanSS,LimanondP,etal. Influenceoflargeperitumoralvesselsonoutcomeofradiofrequencyablationofliver tumors.JVascIntervRadiol.2003;14:1267-1274.(Pubitemid37266660)
51. Yu NC, Kim YJ, Raman SS, Lu DS, Boyadzhyan L, Hsu M. Intraoperative radiofrequency ablation of unresectable liver metastases from colorectal carcinoma: long-term results in 50 patients. Presented at Radiological Society of North America, 92nd Scientific Assembly and Annual Meeting, Chicago, Illinois, November 26-December 1, 2006.
52. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226:441-451. (Pubitemid 36313433)
53. Curley SA, Marra P, Beaty K, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg. 2004;239:450-458. (Pubitemid 38372760)
54. Kondo H, Okumura T, Ohde Y, Nakagawa K. Surgical treatment for metastatic malignancies. Pulmonary metastasis: indications and outcomes. Int J Clin Oncol. 2005;10:81-85. (Pubitemid 40655483)
55. Kawamura M, Izumi Y, Tsukada N, et al. Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates. J Thorac Cardiovasc Surg. 2006;131:1007-1013.
56. Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology. 2007;243:268-275. (Pubitemid 46579719)
57. Steinke K, Glenn D, King J, et al. Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol. 2004;11:207-212. (Pubitemid 40486798)
58. Yan TD, King J, Sjarif A, Glenn D, Steinke K, Morris DL. Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol. 2006;13:1529-1537.
59. Kang S, Luo R, Liao W, Wu H, Zhang X, Meng Y. Single group study to evaluate the feasibility and complications of radiofrequency ablation and usefulness of post treatment position emission tomography in lung tumours. World J Surg Oncol. 2004;2:30. (Pubitemid 40251730)
60. Yasui K, Kanazawa S, Sano Y, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology. 2004;231:850-857. (Pubitemid 38668108)
61. Yan TD, King J, Sjarif A, Glenn D, Steinke K, Morris DL. Learning curve for percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: a prospective study of 70 consecutive cases. Ann Surg Oncol. 2006;13:1588-1595.
62. Ben-Josef E, Normolle D, Ensminger W, et al. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol. 2005;23:8739-8747. (Pubitemid 46211519)
63. Fuss M, Thomas CR Jr. Stereotactic body radiation therapy: an ablative treatment option for primary and secondary liver tumors. Ann Surg Oncol. 2004;11:130-138.
64. HerfarthKK,DebusJ,LohrF,etal.Stereotacticsingle- doseradiationtherapyoflivertumors:resultsofaphaseI/IItrial.JClinOncol.2001;19: 164-170.(Pubitemid32063493)
65. Katz AW, Carey-Sampson M, Muhs AG, Milano MT, Schell MC, Okunieff P. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys. 2007;67:793-798. (Pubitemid 46215888)
66. Kavanagh BD, Schefter TE, Cardenes HR, et al. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol. 2006;45:848-855. (Pubitemid 44423131)
67. Mendez Romero A, Wunderink W, Hussain SM, et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase I-II study. Acta Oncol. 2006;45:831-837. (Pubitemid 44423129)
68. Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys. 2005;62:1371-1378. (Pubitemid 40982057)
69. WulfJ,HadingerU,OppitzU,ThieleW,Ness-DourdoumasR,FlentjeM. Stereotacticradiotherapyoftargetsinthelungandliver.StrahlentherOnkol.2001;177: 645-655.(Pubitemid34015341)
70. Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol. 1995;34:861-870.
71. Dawson LA, Eccles C, Craig T. Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol. 2006;45:856-864. (Pubitemid 44423132)
72. Herfarth KK, Debus J, Wannenmacher M. Stereotactic radiation therapy of liver metastases: update of the initial phase-I/II trial. Front Radiat Ther Oncol. 2004;38:100-105.
73. Jaffray DA. Image-guided radiation therapy: from concept to practice. Semin Radiat Oncol. 2007;17:243-244. (Pubitemid 47446285)
74. Franks KN, Bezjak A, Purdie TG, et al. Early results of image-guided radiation therapy in lung stereotactic body radiotherapy (SBRT). Clin Oncol (R Coll Radiol). 2007;19:S10.
75. Dawson LA, Jaffray DA. Advances in image-guided radiation therapy. J Clin Oncol. 2007;25:938-946. (Pubitemid 350002859)
76. Potters L, Steinberg M, Rose C, et al. American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2004;60:1026-1032. (Pubitemid 39440785)
77. Hoyer M, Henrik R, Traberg Hansen A. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol. 2006;45:823-830. (Pubitemid 44423128)
78. Nagata Y, Negoro Y, Aoki T, et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2002;52:1041-1046. (Pubitemid 34219025)
79. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer. 2004;101:1623-1631. (Pubitemid 39318910)
80. Song DY, Kavanagh BD, Benedict SH, Schefter T. Stereotactic body radiation therapy. Rationale, techniques, applications, and optimization. Oncology (Williston Park). 2004;18:1419-1430; discussion 1430, 1432, 1435-11416
81. Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest. 2003;124:1946-1955. (Pubitemid 37433596)
82. Uematsu M, Shioda A, Tahara K, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer. 1998;82:1062-1070. (Pubitemid 28136518)
83. Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys. 2004;60:186-196. (Pubitemid 39165484)
84. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24:4833-4839. (Pubitemid 46630909)
85. Xiao Y, Straube W, Bosch WR, Timmerman RD, Galvin J. Dosimetric evaluation of heterogeneity corrections for RTOG 0236: hypofractionated radiotherapy of inoperable stage I/II non-small cell lung cancer [abstract]. Int J Radiat Oncol Biol Phys. 2007;69:S46-S47.
86. Schefter T. Stereotactic body radiation therapy: clinical trials at the University of Colorado. Presented at the 4th International Symposium on Stereotactic Body Radiation Therapy, Dallas, Texas, May 26, 2005.
87. Timmerman R, Paulus R, Galvin J, et al. Toxicity analysis of RTOG 0236 using stereotactic body radiation therapy (SBRT) to treat medically inoperable early stage lung cancer patients. Int J Radiat Oncol Biol Phys. 2007;69:S86.
88. BozzettiF,DociR,BignamiP,MorabitoA,GennariL. Patternsoffailurefollowingsurgicalresectionofcolorectalcancerlivermetastases. Rationaleforamultimodalapproach.AnnSurg.1987;205:264-270.(Pubitemid17037049)
89. WagnerJS,AdsonMA,VanHeerdenJA,AdsonMH,IlstrupDM. Thenaturalhistoryofhepaticmetastasesfromcolorectalcancer. Acomparisonwithresectivetreatment.AnnSurg.1984;199:502-508.(Pubitemid14105105)
90. Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol. 1976;2:285-288.
91. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer. 1996;77:1254-1262. (Pubitemid 26102322)
92. EkbergH,TranbergKG,AnderssonR,etal. Patternofrecurrenceinliverresectionforcolorectalsecondaries.WorldJSurg.1987;11: 541-547.(Pubitemid17131696)
93. HughesKS,RosensteinRB,SonghorabodiS,etal. Resectionoftheliverforcolorectalcarcinomametastases.Amulti- institutionalstudyoflong-termsurvivors.DisColonRectum.1988;31:1-4. (Pubitemid18045225)
94. StephensonKR,SteinbergSM,HughesKS,VettoJT,SugarbakerPH,ChangAE. Perioperativebloodtransfusionsareassociatedwithdecreasedtime- recurrenceanddecreasedsurvivalafterresectionofcolorectallivermetastases.AnnSurg. 1988;208:679-687.(Pubitemid19002505)
95. WilsonSM,AdsonMA. Surgicaltreatmentofhepaticmetastasesfromcolorectalcancers.ArchSurg.1976;111: 330-334.(Pubitemid8004414)
96. Petrowsky H, Gonen M, Jarnagin W, et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg. 2002;235:863-871. (Pubitemid 34547306)
97. Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Moriya Y, Sugihara K. Repeat liver resection for recurrent colorectal liver metastases. Am J Surg. 1999;178:275-281.
98. Hohenberger P, Schlag P, Schwarz V, Herfarth C. Tumor recurrence and options for further treatment after resection of liver metastases in patients with colorectal cancer. J Surg Oncol. 1990;44:245-251. (Pubitemid 20269902)
99. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818-825; discussion 825-1817
100. De Baere TJ, Elias D, Ducreux M, et al. Percutaneous radiofrequency of liver metastases: single center experience over a five year period [abstract]. Proc Am Soc Clin Oncol. 2003;22:1387.
101. Gillams AR, Lees WR. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol. 2004;14:2261-2267. (Pubitemid 40057937)
102. Hildebrand P, Kleemann M, Roblick UJ, et al. Radiofrequency-ablation of unresectable primary and secondary liver tumors: results in 88 patients. Langenbecks Arch Surg. 2006;391:118-123.
103. IannittiDA,DupuyDE,Mayo-SmithWW,MurphyB.Hepaticradiofrequencyablation. ArchSurg.2002;137:422-426;discussion427.(Pubitemid34650150)
104. Pereira PL, Classen S, Hoffman RT, Jacobs TS, Herberts T, Helmberger TK. Long term survival after CT and MR guided percutaneous radiofrequency ablation of colorectal metastases: clinical results of the German study group. Presented at Radiological Society of North America, 92nd Scientific Assembly and Annual Meeting, Chicago, Illinois, November 26-December 1, 2006.
105. Siperstein AE, Berber E, Ballem N, Parikh RT. Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg. 2007;246:559-565; discussion 565-1557 (Pubitemid 47480598)
106. Solbiati L, Ierace T, Brioschi M, Cova L. Radiofrequency ablation of liver metastases of colorectal origin with intention to treat: local response rate and long-term survival over 7-year follow-up. Presented at Radiological Society of North America, 92nd Scientific Assembly and Annual Meeting, Chicago, Illinois, November 26-December 1, 2006.
107. Solbiati L, Ierace T, Livraghi T, Meloni F, Goldberg SN, Gazelle GS. Outcome and long-term survival of patients with liver metastases from colorectal cancer treated with percutaneous cool-tip radiofrequency ablation. Radiology. 2001;221(suppl):623-625.
108. Hildebrand P, Leibecke T, Kleemann M, et al. Influence of operator experience in radiofrequency ablation of malignant liver tumours on treatment outcome. Eur J Surg Oncol. 2006;32:430-434. (Pubitemid 44287671)
109. Wood BJ, Locklin JK, Viswanathan A, et al. Technologies for guidance of radiofrequency ablation in the multimodality interventional suite of the future. J Vasc Interv Radiol. 2007;18:9-24. (Pubitemid 46628942)
110. Anaya C, Raman SR, Gomez AM, Lu DS. Percutaneous radiofrequency ablation of peri-intestinal hepatic tumors: initial experience with hydrodisplacemnt technique. Presented at the Annual Meeting of the American Roentgen Ray Society, Orlando, Florida, May 6-11, 2007.
111. Oshowo A, Gillams A, Harrison E, Lees WR, Taylor I. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg. 2003;90:1240-1243. (Pubitemid 37330428)
112. Mulier S, Ni Y, Jamart J, Michel L, Marchal G, Ruers T. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol. 2008;15:144-157.
113. Lambert LA, Colacchio TA, Barth RJ. Interval hepatic resection of colorectal metastases improves patient selection*. Curr Surg. 2000;57:504.
114. Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, Gazelle GS. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach." Cancer. 2003;97:3027-3035.
115. Mala T, Bohler G, Mathisen O, Bergan A, Soreide O. Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg. 2002;26:1348-1353. (Pubitemid 36920229)
116. Schussler-Fiorenza CM, Mahvi DM, Niederhuber J, Rikkers LF, Weber SM. Clinical risk score correlates with yield of PET scan in patients with colorectal hepatic metastases. J Gastrointest Surg. 2004;8:150-157; discussion 157-158. (Pubitemid 38224256)
117. Jarnagin WR, Conlon K, Bodniewicz J, et al. A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer. 2001;91:1121-1128. (Pubitemid 32295417)
118. Chen YY, Perera DS, Yan TD, Schmidt LM, Morris DL. Applying Fong's CRS liver score in patients with colorectal liver metastases treated by cryotherapy. Asian J Surg. 2006;29:238-241.
119. Kattan MW Gonen M, Jarnagin WR, et al. A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Ann Surg. 2008;247:282-287.
120. AshleyAC,DeschampsC,AlbertsSR. Impactofprognosticfactorsonclinicaloutcomeafterresectionofcolorectal pulmonarymetastases.ClinColorectalCancer.2006;6:32-37.(Pubitemid44043999)
121. Koga R, Yamamoto J, Saiura A, Yamaguchi T, Hata E, Sakamoto M. Surgical resection of pulmonary metastases from colorectal cancer: four favourable prognostic factors. Jpn J Clin Oncol. 2006;36:643-648.
122. Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg. 2007;84:324-338. (Pubitemid 46921128)
123. Iizasa T, Suzuki M, Yoshida S, et al. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer. Ann Thorac Surg. 2006;82:254-260. (Pubitemid 43913624)
124. Yedibela S, Klein P, Feuchter K, et al. Surgical management of pulmonary metastases from colorectal cancer in 153 patients. Ann Surg Oncol. 2006;13:1538-1544.
125. King J, Glenn D, Clark W, et al. Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer. Br J Surg. 2004;91:217-223. (Pubitemid 38233968)
126. Divisi D, Gizzonio D, Crisci R. Multimodal treatment of osteosarcoma lung metastases. Thorac Cardiovasc Surg. 2006;54:328-331. (Pubitemid 44366242)
127. Pfannschmidt J, Klode J, Muley T, Dienemann H, Hoffmann H. Pulmonary metastasectomy in patients with soft tissue sarcomas: experiences in 50 patients. Thorac Cardiovasc Surg. 2006;54:489-492. (Pubitemid 44682687)
128. BelalA,SalahE,HajjarW,etal.Pulmonarymetastatectomyforsofttissuesarcomas: isitvaluable?JCardiovascSurg(Torino).2001;42:835-840.(Pubitemid33138758)
129. Pappo AS, Rao BN, Jenkins JJ, et al. Metastatic nonrhabdomyosarcomatous soft-tissue sarcomas in children and adolescents: the St. Jude Children's Research Hospital experience. Med Pediatr Oncol. 1999;33:76-82. (Pubitemid 29340013)
130. Suzuki M, Iwata T, Ando S, et al. Predictors of long-term survival with pulmonary metastasectomy for osteosarcomas and soft tissue sarcomas. J Cardiovasc Surg (Torino). 2006;47:603-608.
131. Rehders A, Hosch SB, Scheunemann P, Stoecklein NH, Knoefel WT, Peiper M. Benefit of surgical treatment of lung metastasis in soft tissue sarcoma. Arch Surg. 2007;142:70-75; discussion 76. (Pubitemid 46106049)
132. Pfannschmidt J, Klode J, Muley T, Hoffmann H, Dienemann H. Pulmonary resection for metastatic osteosarcomas: a retrospective analysis of 21 patients. Thorac Cardiovasc Surg. 2006;54:120-123.
133. Berber E, Ari E, Herceg N, Siperstein A. Laparoscopic radiofrequency thermal ablation for unusual hepatic tumors: operative indications and outcomes. Surg Endosc. 2005;19:1613-1617. (Pubitemid 41719530)
134. Lee EW, Raman SR, Yu NC, Economou JS, Lu DSK. Intraoperative hepatic radiofrequency ablation of metastatic sarcoma. Presented at Proceedings of the Annual Meeting of the Radiological Society of North America, Chicago, Illinois, November 26-December 1, 2006.
135. PawlikTM,VautheyJN,AbdallaEK,PollockRE,EllisLM,CurleySA. Resultsofasingle- centerexperiencewithresectionandablationforsarcomametastatictotheliver.ArchSurg. 2006;141:537-543;discussion543-544.(Pubitemid43920666)
136. GoldhirschA,GelberRD,CastiglioneM. Relapseofbreastcancerafteradjuvanttreatmentinpremenopausalandperi menopausalwomen:patternsandprognoses.JClinOncol.1988;6:89-97.(Pubitemid18039996)
137. O'Reilly SM, Richards MA, Rubens RD. Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival. Eur J Cancer. 1990;26:574-577. (Pubitemid 20259332)
138. Wyld L, Gutteridge E, Pinder SE, et al. Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer. 2003;89:284-290. (Pubitemid 36976317)
139. Adam R, Aloia T, Krissat J, et al. Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg. 2006;244:897-907; discussion 907-1898
140. CarliniM,LonardoMT,CarboniF,etal.Livermetastasesfrombreastcancer. Resultsofsurgicalresection.Hepatogastroenterology.2002;49:1597-1601. (Pubitemid35277335)
141. d'Annibale M, Piovanello P, Cerasoli V, Campioni N. Liver metastases from breast cancer: the role of surgical treatment. Hepatogastroenterology. 2005;52:1858-1862.
142. Ercolani G, Grazi GL, Ravaioli M, et al. The role of liver resections for noncolorectal, nonneuroendocrine metastases: experience with 142 observed cases. Ann Surg Oncol. 2005;12:459-466. (Pubitemid 40884260)
143. Lorenz M, Wiesner J, Staib-Sebler E, Encke A. [Regional therapy breast cancer liver metastases]. Zentralbl Chir. 1995;120:786-790.
144. Maksan SM, Lehnert T, Bastert G, Herfarth C. Curative liver resection for metastatic breast cancer. Eur J Surg Oncol. 2000;26:209-212. (Pubitemid 30319223)
145. RaabR,NussbaumKT,BehrendM,WeimannA.Livermetastasesofbreastcancer: resultsofliverresection.AnticancerRes.1998;18:2231-2233.(Pubitemid28386496)
146. SchneebaumS,WalkerMJ,YoungD,FarrarWB,MintonJP. Theregionaltreatmentoflivermetastasesfrombreastcancer.JSurgOncol.1994;55: 26-31;discussion32.(Pubitemid24048386)
147. SelznerM,MorseMA,VredenburghJJ,MeyersWC,ClavienPA. Livermetastasesfrombreastcancer:long-termsurvivalaftercurativeresection.Surgery. 2000;127:383-389.(Pubitemid30225989)
148. StehlinJSJr,deIpolyiPD,GreeffPJ,McGaffCJJr,DavisBR,McNaryL. Treatmentofcanceroftheliver. Twentyyears'experiencewithinfusionandresectionin414patients.AnnSurg.1988;208: 23-35.(Pubitemid18169539)
149. Vlastos G, Smith DL, Singletary SE, et al. Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol. 2004;11:869-874. (Pubitemid 40568815)
150. Yoshimoto M, Tada T, Saito M, Takahashi K, Uchida Y, Kasumi F. Surgical treatment of hepatic metastases from breast cancer. Breast Cancer Res Treat. 2000;59:177-184. (Pubitemid 30216141)
151. LivraghiT,GoldbergSN,SolbiatiL,MeloniF,IeraceT,GazelleGS. Percutaneousradio-frequencyablationoflivermetastasesfrombreastcancer: initialexperiencein24patients.Radiology.2001;220:145-149.(Pubitemid32577975)
152. Sofocleous CT, Nascimento RG, Gonen M, et al. Radiofrequency ablation in the management of liver metastases from breast cancer. AJR Am J Roentgenol. 2007;189:883-889. (Pubitemid 47479772)
153. Milano MT, Katz AW, Muhs AG, et al. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer. 2008;112:650-658.
154. Barth A, Wanek LA, Morton DL. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg. 1995;181:193-201.
155. Essner R, Lee JH, Wanek LA, Itakura H, Morton DL. Contemporary surgical treatment of advanced-stage melanoma. Arch Surg. 2004;139:961-966; discussion 966-967. (Pubitemid 39186745)
156. Adam R, Chiche L, Aloia T, et al. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg. 2006;244:524-535. (Pubitemid 44435756)
157. Herman P, Machado MA, Montagnini AL, D'Albuquerque LA, Saad WA, Machado MC. Selected patients with metastatic melanoma may benefit from liver resection. World J Surg. 2007;31:171-174. (Pubitemid 46089562)
158. Petersen RP, Hanish SI, Haney JC, et al. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg. 2007;133:104-110.
159. vanderPoelHG,RoukemaJA,HorenblasS,vanGeelAN,DebruyneFM. Metastasectomyinrenalcellcarcinoma:amulticenterretrospectiveanalysis.EurUrol. 1999;35:197-203.(Pubitemid29108145)
160. DekernionJB,RammingKP,SmithRB. Thenaturalhistoryofmetastaticrenalcellcarcinoma:acomputeranalysis.JUrol. 1978;120:148-152.(Pubitemid9005387)
161. Assouad J, Riquet M, Berna P, Danel C. Intrapulmonary lymph node metastasis and renal cell carcinoma. Eur J Cardiothorac Surg. 2007;31:132-134.
162. Hofmann HS, Neef H, Krohe K, Andreev P, Silber RE. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol. 2005;48:77-81; discussion 81-172 (Pubitemid 40835595)
163. Pfannschmidt J, Hoffmann H, Muley T, Krysa S, Trainer C, Dienemann H. Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg. 2002;74:1653-1657. (Pubitemid 35222660)
164. Liu D, Abolhoda A, Burt ME, et al. Pulmonary metastasectomy for testicular germ cell tumors: a 28-year experience. Ann Thorac Surg. 1998;66:1709-1714. (Pubitemid 29030176)
165. Pfannschmidt J, Zabeck H, Muley T, Dienemann H, Hoffmann H. Pulmonary metastasectomy following chemotherapy in patients with testicular tumors: experience in 52 patients. Thorac Cardiovasc Surg. 2006;54:484-488. (Pubitemid 44682686)
166. Cohn DA, Stuart-Harris R. Isolated central nervous system relapse of non-seminomatous germ cell tumour of the testis. A case report and review of the literature. Oncology. 2001;61:184-188. (Pubitemid 34701531)
167. Flechon A, Rivoire M, Berger N. [Surgery of residual masses after chemotherapy in patients with testicular cancer]. Rev Prat. 2007;57:389-398.
168. Kesler KA, Brooks JA, Rieger KM, Fineberg NS, Einhorn LH, Brown JW. Mediastinal metastases from testicular nonseminomatous germ cell tumors: patterns of dissemination and predictors of long-term survival with surgery. J Thorac Cardiovasc Surg. 2003;125:913-923. (Pubitemid 36457514)
169. Kesler KA, Wilson JL, Cosgrove JA, et al. Surgical salvage therapy for malignant intrathoracic metastases from nonseminomatous germ cell cancer of testicular origin: analysis of a single-institution experience. J Thorac Cardiovasc Surg. 2005;130:408-415. (Pubitemid 41074172)
170. Blomgren J, Lax I, Goranson H, et al. Radiosurgery for tumors in the body: clinical experience using a new method. J Radiosurg. 1998;1:63-74.
171. GunvenP,BlomgrenH,LaxI. Radiosurgeryforrecurringlivermetastasesafterhepatectomy.Hepatogastroenterology. 2003;50:1201-1204.(Pubitemid37186444)
172. Zerbini A, Pilli M, Penna A, et al. Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses. Cancer Res. 2006;66:1139-1146. (Pubitemid 43165983)
173. HanslerJ,WissniowskiTT,SchuppanD,etal. ActivationanddramaticallyincreasedcytolyticactivityoftumorspecificT lymphocytesafterradio- frequencyablationinpatientswithhepatocellularcarcinomaandcolorectal livermetastases.WorldJGastroenterol.2006;12:3716-3721.(Pubitemid43958380)
174. Chakravarty PK, Guha C, Alfieri A, et al. Flt3L therapy following localized tumor irradiation generates long-term protective immune response in metastatic lung cancer: its implication in designing a vaccination strategy. Oncology. 2006;70:245-254. (Pubitemid 44670164)
175. Shah SA, Bromberg R, Coates A, Rempel E, Simunovic M, Gallinger S. Survival after liver resection for metastatic colorectal carcinoma in a large population. J Am Coll Surg. 2007;205:676-683. (Pubitemid 47615495)
176. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247:125-135.
177. Bleicher RJ, Allegra DP, Nora DT, Wood TF, Foshag LJ, Bilchik AJ. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol. 2003;10:52-58.
178. Elias D, Baton O, Sideris L, Matsuhisa T, Pocard M, Lasser P. Local recurrences after intraoperative radiofrequency ablation of liver metastases: a comparative study with anatomic and wedge resections. Ann Surg Oncol. 2004;11:500-505. (Pubitemid 40486731)
179. Nakagawa K, Aoki Y, Tago M, Terahara A, Ohtomo K. Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: original research in the treatment of thoracic neoplasms. Int J Radiat Oncol Biol Phys. 2000;48:449-457.
180. Hara R, Itami J, Kondo T, et al. Stereotactic single high dose irradiation of lung tumors under respiratory gating. Radiother Oncol. 2002;63:159-163. (Pubitemid 34628404)
181. Lee SW, Choi EK, Park HJ, et al. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer. 2003;40:309-315. (Pubitemid 36627711)
182. Whyte RI, Crownover R, Murphy MJ, et al. Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trial. Ann Thorac Surg. 2003;75:1097-1101. (Pubitemid 36399383)
183. Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol. 2006;13:668-676. (Pubitemid 43356222)